학술논문

A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease
Document Type
Article
Source
In: Neurology. (Neurology, 2018, 90(21):E1889-E1897)
Subject
Language
English
ISSN
1526632X
00283878